300705SZSE

Announcement of Resolutions from the 18th Meeting of the 4th Board of Directors

✨ AI Summary

The 18th meeting of the 4th Board of Directors of Hunan Jiudian Pharmaceutical Co., Ltd. was held on June 3, 2026. The board unanimously decided not to lower the conversion price of the Jiudian Convertible Bonds (No. 02) despite meeting conditions for adjustment. This decision aims to protect the long-term interests of all shareholders and creditors. The voting results were 7 in favor, with no abstentions or objections.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

I. Meeting Information

The 18th meeting of the 4th Board of Directors of Hunan Jiudian Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") was held on June 3, 2026, in the Company’s conference room 921, combining in-person and telecommunication methods. All directors agreed to waive the notice period requirement, and the meeting notice was delivered via email on June 3, 2026. A total of 7 directors were supposed to attend, and all 7 directors were present (among them, the following directors attended via telecommunication: Mr. Yang Yang, Mr. Fan Pengyun, Mr. Lu Shang, Ms. Yang Qiulin, Mr. Zhou Congshan, Ms. Xiang Jing). All senior management personnel attended the meeting, which was convened and presided over by Chairman Mr. Zhu Zhihong.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.